Literature DB >> 12633185

Hepatitis C virus and atherosclerosis in patients with type 2 diabetes.

Michiaki Fukui, Yoshihiro Kitagawa, Naoto Nakamura, Toshikazu Yoshikawa.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12633185     DOI： 10.1001/jama.289.10.1245-b

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  34 in total

1.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

Review 2.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 3.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

4.  Higher Prevalence and More Severe Coronary Artery Disease in Hepatitis C Virus-infected Patients: A Case Control Study.

Authors:  Sanjaya K Satapathy; Yun Ju Kim; Ashish Kataria; Arash Shifteh; Rohan Bhansali; Maurice A Cerulli; David Bernstein
Journal:  J Clin Exp Hepatol       Date:  2013-06-11

5.  The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals.

Authors:  Matthew S Freiberg; Debbie M Cheng; Kevin L Kraemer; Richard Saitz; Lewis H Kuller; Jeffrey H Samet
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

Review 6.  Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.

Authors:  Luigi Elio Adinolfi; Riccardo Nevola; Giacomo Lus; Luciano Restivo; Barbara Guerrera; Ciro Romano; Rosa Zampino; Luca Rinaldi; Ausilia Sellitto; Mauro Giordano; Aldo Marrone
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 7.  Neurological complications of hepatitis C infection.

Authors:  Micheline McCarthy; Melissa R Ortega
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

8.  The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Melissa Skanderson; Kathleen McGinnis; Lewis H Kuller; Kevin L Kraemer; David Rimland; Matthew B Goetz; Adeel A Butt; Maria C Rodriguez Barradas; Cynthia Gibert; David Leaf; Sheldon T Brown; Jeffrey Samet; Lewis Kazis; Kendall Bryant; Amy C Justice
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-06-28

9.  Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).

Authors:  Elizabeth M Kiefer; Qiuhu Shi; Donald R Hoover; Robert Kaplan; Russell Tracy; Michael Augenbraun; Chenglong Liu; Marek Nowicki; Phyllis C Tien; Mardge Cohen; Elizabeth T Golub; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

10.  Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.

Authors:  Judith Tsui; Eric Vittinghoff; Kathryn Anastos; Michael Augenbraun; Mary Young; Marek Nowicki; Mardge H Cohen; Marion G Peters; Elizabeth T Golub; Lynda Szczech
Journal:  Am J Kidney Dis       Date:  2009-04-25       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.